Amundi
ACH

Amundi’s Accendra Health ACH Stock Holding History

Amundi’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-45,498
Closed -$423K – 1655
2025
Q2 		$423K Buy
45,498
+18,559
+69% +$137K ﹤0.01% 1416
2025
Q1 		$231K Sell
26,939
-9,364
-26% -$98.9K ﹤0.01% 1653
2024
Q4 		$523K Buy
36,303
+23,294
+179% +$311K ﹤0.01% 1555
2024
Q3 		$177K Buy
13,009
+1,285
+11% +$19.5K ﹤0.01% 1676
2024
Q2 		$154K Sell
11,724
-1,689
-13% -$34.6K ﹤0.01% 1630
2024
Q1 		$323K Buy
13,413
+3,472
+35% +$77.1K ﹤0.01% 1528
2023
Q4 		$192K Buy
9,941
+403
+4% +$7.3K ﹤0.01% 1642
2023
Q3 		$141K Sell
9,538
-423
-4% -$7.51K ﹤0.01% 1680
2023
Q2 		$187K Sell
9,961
-306
-3% -$5.46K ﹤0.01% 1620
2023
Q1 		$151K Buy
+10,267
New +$184K ﹤0.01% 1645
2021
Q3 		– Sell
-211,400
Closed -$8.95M – 1613
2021
Q2 		$8.95M Buy
+211,400
New +$8.22M 0.01% 875

Other funds holding ACH

CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Amundi's ACH Position: Q3 2025 in Review

Amundi sold out of Accendra Health (ACH) in Q3 2025, closing a stake of 45,498 shares — an estimated $423K sold.

Amundi first reported a position in ACH in Q2 2021 and held it in 11 quarters. The position peaked at $8.95M in Q2 2021. 202 funds tracked by Wall St. Rank hold ACH as of Q3 2025.

  • Amundi reported no remaining Accendra Health position as of Q3 2025 after selling out during the quarter.
  • Amundi sold 45,498 Accendra Health shares in Q3 2025, an estimated $423K.
  • Amundi first reported a position in Accendra Health in Q2 2021 and held it in 11 quarters.
  • Amundi's Accendra Health position peaked at $8.95M in Q2 2021.
  • 202 funds tracked by Wall St. Rank held Accendra Health as of Q3 2025.

Based on Amundi's 13F filing for Q3 2025, filed 14 Nov 2025.